Drug ID: | NPD6006 |
Drug Name: | |
Molecular Formula: | C24H30O5 |
Canonical SMILES: | CC#CCC(C(/C=C/C1C(O)CC2C1c1cccc(c1O2)CCCC(=O)[O-])O)C |
Standard InCHI: | InChI=1S/C24H30O5/c1-3-4-7-15(2)19(25)13-12-17-20(26)14-21-23(17)18-10-5-8-16(24(18)29-21)9-6-11-22(27)28/h5,8,10,12-13,15,17,19-21,23,25-26H,6-7,9,11,14H2,1-2H3,(H,27,28)/p-1/b13-12+ |
Standard InCHIKey: | CTPOHARTNNSRSR-OUKQBFOZSA-M |
Max Developmental Stage: | Clinical (unspecified phase) |
Max Developmental Stage Source: | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DNCL003336 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | 23676207 |
ChEBI | |
CAS Number |
Molecular Weight | 397.20 |
ALogP | -0.8079 |
MLogP | 3.55 |
XLogP | 2.953 |
HDA | 4 |
HBD | 2 |
Rotatable Bonds | 12 |
TPSA | 89.82 |
RO5 Violation | 0 |